The importance of Th17 prevalence is also confirmed by the studies of Hull et al., who found that Th17 cell frequency increases during anti-TNF therapy in RA, AS and psoriatic arthritis, and the increase is associated with the improvement of synovitis in RA (Hull et al. 2015, 2016). The gene discussed is TNF; the disease is rheumatoid arthritis.